查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1710264

糞便微生物移植（FMT）全球市場報告（2025）

Fecal Microbiota Transplantation (FMT) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計糞便微生物移植 (FMT) 市場規模將在未來幾年內出現強勁成長。預計到 2029 年將成長至 11.9 億美元，複合年成長率為 6.9%。預測期內的成長歸因於困難梭狀芽孢桿菌傳染病(CDI) 發病率的增加、發炎性腸道疾病病率的上升、研發活動的增加、老年人口的成長以及醫療保健基礎設施的擴大。預測期內的關鍵趨勢包括捐贈者篩檢、糞便準備的標準化通訊協定的製定、微生物組分析的進展、糞便處理技術的改進、新穎的遞送方法以及基於合成或標準化微生物群的產品的開發。

預計未來幾年胃腸道疾病發病率的增加將刺激糞便微生物移植 (FMT) 市場的擴張。胃腸道 (GI) 疾病包括影響消化道的多種疾病，包括食道、胃、小腸、大腸（結腸）、直腸和肛門。導致胃腸道疾病增加的因素包括壓力水平增加、久坐習慣和加工食品攝取量增加。糞便微生物移植被用於恢復胃腸道疾病患者的健康腸道細菌，特別是在治療復發性困難梭狀芽孢桿菌傳染病。例如，非營利組織加拿大克隆氏症和結腸炎協會報告稱，加拿大患有發炎性腸道疾病(IBD) 的人數正在迅速成長，預計將從 2023 年的 322,600 人（佔人口的 0.8%）成長到 2035 年的 470,000 人（佔人口的 1.1%）。預計 2023 年將診斷出 11,000 個新病例（約每 48 分鐘 1 例），到 2035 年將增加到 14,000 例（約每 38 分鐘 1 例）。因此，胃腸道疾病盛行率的上升是推動糞便微生物移植 (FMT) 市場成長的關鍵因素。

糞便微生物移植 (FMT) 市場的主要企業正專注於開發創新解決方案，例如基於微生物的活生物治療，以改善胃腸道疾病的治療效果。基於微生物群的活生物治療涉及使用活微生物作為治療劑來恢復或改變腸道微生物群以治療各種疾病。例如，2022年11月，瑞士生物製藥公司Ferring Pharmaceuticals的REBYOTA（糞便微生物組，live-jslm）獲得了美國食品藥物管理局（FDA）的核准。這種新型、一流的、基於活微生物組的生物治療藥物旨在預防 18 歲或以上個體在接受復發性艱難梭菌感染疾病(CDI) 抗生素治療後復發。 REBYOTA 專門用於預防該年齡層艱難梭菌感染疾病治療後的復發。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球糞便微生物移植（FMT）PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球糞便微生物移植（FMT）市場：成長率分析
  • 全球糞便微生物移植 (FMT) 市場表現：規模與成長，2019-2024 年
  • 全球糞便微生物移植 (FMT) 市場預測：2024-2029 年及 2034 年規模與成長
  • 全球糞便微生物移植（FMT）總目標市場（TAM）

第6章市場區隔

  • 全球糞便微生物移植 (FMT) 市場類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 發酵
  • 新鮮的
  • 冷凍保存
  • 全球糞便微生物移植 (FMT) 市場（按捐贈者類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 糞便來源
  • 糞便來源
  • 整個微生物組的起源
  • 全球糞便微生物移植 (FMT) 市場（按適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 困難梭狀桿菌感染疾病
  • 發炎性腸道疾病
  • METABOLIC INC.症候群
  • 其他適應症
  • 全球糞便微生物移植 (FMT) 市場（按給藥途徑、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 直腸
  • 鼻胃管
  • 結腸膠囊
  • 全球糞便微生物移植 (FMT) 市場（按最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 其他最終用戶
  • 全球糞便微生物移植 (FMT) 市場、發酵細分市場、類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 發酵FMT產品
  • 發酵膠囊
  • 發酵液
  • 內部發酵技術
  • 全球糞便微生物移植 (FMT) 市場，新鮮度細分，按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 新鮮糞便樣本
  • 新鮮FMT膠囊
  • 適用於臨床使用的新鮮 FMT 溶液
  • 為門診病人準備的新鮮FMT
  • 全球糞便微生物移植 (FMT) 市場，依冷凍保存類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 冷凍糞便樣本
  • 冷凍保存的FMT膠囊
  • 冷凍保存液體FMT
  • 冷凍保存 FMT 的長期儲存解決方案

第7章 區域和國家分析

  • 全球糞便微生物移植 (FMT) 市場各地區、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 全球糞便微生物移植 (FMT) 市場（按國家/地區分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 糞便微生物移植（FMT）市場：競爭格局
  • 糞便微生物移植（FMT）市場：公司簡介
    • Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
    • Johns Hopkins Medicine Overview, Products and Services, Strategy and Financial Analysis
    • Seres Therapeutics Overview, Products and Services, Strategy and Financial Analysis
    • Taconic Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • Enterome Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Rebiotix Inc
  • Finch Therapeutics Group Inc
  • Locus Biosciences
  • Yeda Research and Development Co. Ltd
  • Microbiotica Limited
  • CosmosID Inc
  • AOBiome
  • Synthetic Biologics Inc.
  • Osel Inc.
  • OpenBiome
  • Asia Microbiota Bank
  • Taymount Clinic
  • MicroBiome Therapeutics LLC
  • MaaT Pharma SA
  • Kallyope

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 糞便微生物移植 (FMT) 市場 2029：提供新機會的國家
  • 糞便微生物移植 (FMT) 市場 2029：細分領域帶來新機會
  • 糞便微生物移植 (FMT) 市場 2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31843

Fecal microbiota transplantation (FMT) is a medical procedure where a healthy donor's fecal material is transplanted into a recipient's gastrointestinal tract to restore the balance of beneficial microorganisms in the gut. This procedure is typically used to treat conditions where the gut microbiota is disrupted, such as recurrent clostridium difficile infection (CDI) that does not respond to standard treatments.

The main types of fecal microbiota transplantation (FMT) are fermentation, fresh, and cryopreservation. Fermentation in Fecal Microbiota Transplantation (FMT) refers to the process by which gut bacteria break down complex carbohydrates and fibers in the gastrointestinal tract, producing short-chain fatty acids and other metabolites that promote gut health. Donor types include stool-derived, fecal-derived, and whole-microbiome derived, used to treat various conditions such as Clostridioides difficile infection, inflammatory bowel disease, metabolic syndrome, and others. It is administered through oral, rectal, nasogastric, and colon capsule routes. The end users include hospitals, specialty clinics, and others.

The fecal microbiota transplantation (FMT) market research report is one of a series of new reports from The Business Research Company that provides fecal microbiota transplantation (FMT) market statistics, including the fecal microbiota transplantation (FMT) industry's global market size, regional shares, competitors with a fecal microbiota transplantation (FMT) market share, detailed fecal microbiota transplantation (FMT) market segments, market trends and opportunities, and any further data you may need to thrive in the fecal microbiota transplantation (FMT) industry. This fecal microbiota transplantation (FMT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fecal microbiota transplantation (FMT) market size has grown strongly in recent years. It will grow from $0.85 $ billion in 2024 to $0.91 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing awareness of gut microbiome, expanding therapeutic applications, increasing personalized medicine, adoption in gastroenterology practices, increasing number of clinical trials and increasing funding and investments.

The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.19 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing incidence of clostridium difficile infections (CDI), rising prevalence of inflammatory bowel diseases, increasing research and development activities, rising geriatric population, and expanding healthcare infrastructure. Major trends in the forecast period include the development of standardized protocols for donor screening, stool preparation, advances in microbiome analysis, improved stool processing technologies, novel delivery methods, and the development of synthetic or standardized microbiota-based products.

The increasing incidence of gastrointestinal disorders is anticipated to fuel the expansion of the fecal microbiota transplantation (FMT) market in the future. Gastrointestinal (GI) disorders encompass a variety of conditions that impact the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine (colon), rectum, and anus. Factors contributing to the rise in GI disorders include heightened stress levels, sedentary habits, and a greater intake of processed foods. Fecal microbiota transplantation is utilized to restore healthy gut bacteria in patients with gastrointestinal disorders, particularly for the treatment of recurrent Clostridioides difficile infections. For example, Crohn's and Colitis Canada, a non-profit organization, reported that the number of individuals with inflammatory bowel disease (IBD) in Canada is rapidly increasing, projected to rise from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). In 2023, 11,000 new cases are expected to be diagnosed (approximately one every 48 minutes), with this number increasing to 14,000 by 2035 (approximately one every 38 minutes). Consequently, the growing prevalence of gastrointestinal disorders is a significant factor driving the growth of the fecal microbiota transplantation (FMT) market.

Leading companies in the fecal microbiota transplantation (FMT) market are concentrating on developing innovative solutions, such as microbiota-based live biotherapeutics, to improve treatment effectiveness for gastrointestinal disorders. Microbiota-based live biotherapeutics involve using live microorganisms as therapeutic agents to restore or alter the gut microbiome for treating various diseases. For example, in November 2022, Ferring Pharmaceuticals, a biopharmaceutical company based in Switzerland, received approval from the US Food and Drug Administration (FDA) for REBYOTA (fecal microbiota, live-jslm). This novel, first-in-class microbiota-based live biotherapeutic is designed to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals aged 18 and older, following antibiotic treatment for recurrent CDI. REBYOTA is specifically indicated for preventing the recurrence of Clostridioides difficile (C. difficile) infection in this age group after such treatment.

In October 2022, SYNLAB Group, a Germany-based provider of medical diagnostic services, formed a partnership with Microba to improve access to advanced microbiome analysis and enhance patient health management. The collaboration aims to expand the availability of the myBIOME test across Europe and Latin America, building on its success in Spain and Colombia. Microba, an Australia-based biotechnology company, specializes in fecal microbiota transplantation (FMT) research and application.

Major companies operating in the fecal microbiota transplantation (FMT) market are Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc, Finch Therapeutics Group Inc, Locus Biosciences, Yeda Research and Development Co. Ltd, Microbiotica Limited, CosmosID Inc, AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope

North America was the largest region in the fecal microbiota transplantation (FMT) market in 2023. The regions covered in the fecal microbiota transplantation (FMT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fecal microbiota transplantation (FMT) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fecal microbiota transplantation (FMT) market consists of revenues earned by entities by providing services such as donor screening and testing, microbiome assessment, stool collection, processing and preparation, endoscopic delivery, clinical monitoring, and symptom management. The market value includes the value of related goods sold by the service provider or included within the service offering. The fecal microbiota transplantation (FMT) market also includes sales of oral capsules, colonoscopy-based FMT, nasogastric or nasoduodenal tube and lyophilized (freeze-dried) stool. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fecal Microbiota Transplantation (FMT) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fecal microbiota transplantation (fmt) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fecal microbiota transplantation (fmt) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fecal microbiota transplantation (fmt) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Fermentation; Fresh; Cryopreservation
  • 2) By Donor Type: Stool-Derived; Fecal-Derived; Whole-Microbiome Derived
  • 3) By Indication: Clostridioides Difficile Infection; Inflammatory Bowel Disease; Metabolic Syndrome; Other Indications
  • 4) By Administration Route: Oral; Rectal; Nasogastric; Colon Capsule
  • 5) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Fermentation: Fermented FMT Products; Fermented Capsules; Fermented Liquids; In-House Fermentation Techniques
  • 2) By Fresh: Fresh Stool Samples; Fresh FMT Capsules; Fresh FMT Solutions for In-Hospital Use; Freshly Prepared FMT for Outpatient Use
  • 3) By Cryopreservation: Cryopreserved Stool Samples; Cryopreserved FMT Capsules; Cryopreserved Liquid FMT; Long-Term Storage Solutions for Cryopreserved FMT
  • Companies Mentioned: Ferring Pharmaceuticals; Johns Hopkins Medicine; Seres Therapeutics; Taconic Biosciences; Enterome
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fecal Microbiota Transplantation (FMT) Market Characteristics

3. Fecal Microbiota Transplantation (FMT) Market Trends And Strategies

4. Fecal Microbiota Transplantation (FMT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fecal Microbiota Transplantation (FMT) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Fecal Microbiota Transplantation (FMT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Fecal Microbiota Transplantation (FMT) Market Growth Rate Analysis
  • 5.4. Global Fecal Microbiota Transplantation (FMT) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Fecal Microbiota Transplantation (FMT) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Fecal Microbiota Transplantation (FMT) Total Addressable Market (TAM)

6. Fecal Microbiota Transplantation (FMT) Market Segmentation

  • 6.1. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fermentation
  • Fresh
  • Cryopreservation
  • 6.2. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stool-Derived
  • Fecal-Derived
  • Whole-Microbiome Derived
  • 6.3. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clostridioides Difficile Infection
  • Inflammatory Bowel Disease
  • Metabolic Syndrome
  • Other Indications
  • 6.4. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Rectal
  • Nasogastric
  • Colon Capsule
  • 6.5. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users
  • 6.6. Global Fecal Microbiota Transplantation (FMT) Market, Sub-Segmentation Of Fermentation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fermented FMT Products
  • Fermented Capsules
  • Fermented Liquids
  • In-House Fermentation Techniques
  • 6.7. Global Fecal Microbiota Transplantation (FMT) Market, Sub-Segmentation Of Fresh, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fresh Stool Samples
  • Fresh FMT Capsules
  • Fresh FMT Solutions for In-Hospital Use
  • Freshly Prepared FMT for Outpatient Use
  • 6.8. Global Fecal Microbiota Transplantation (FMT) Market, Sub-Segmentation Of Cryopreservation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cryopreserved Stool Samples
  • Cryopreserved FMT Capsules
  • Cryopreserved Liquid FMT
  • Long-Term Storage Solutions for Cryopreserved FMT

7. Fecal Microbiota Transplantation (FMT) Market Regional And Country Analysis

  • 7.1. Global Fecal Microbiota Transplantation (FMT) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Fecal Microbiota Transplantation (FMT) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market

  • 8.1. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fecal Microbiota Transplantation (FMT) Market

  • 9.1. China Fecal Microbiota Transplantation (FMT) Market Overview
  • 9.2. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fecal Microbiota Transplantation (FMT) Market

  • 10.1. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fecal Microbiota Transplantation (FMT) Market

  • 11.1. Japan Fecal Microbiota Transplantation (FMT) Market Overview
  • 11.2. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fecal Microbiota Transplantation (FMT) Market

  • 12.1. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fecal Microbiota Transplantation (FMT) Market

  • 13.1. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fecal Microbiota Transplantation (FMT) Market

  • 14.1. South Korea Fecal Microbiota Transplantation (FMT) Market Overview
  • 14.2. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fecal Microbiota Transplantation (FMT) Market

  • 15.1. Western Europe Fecal Microbiota Transplantation (FMT) Market Overview
  • 15.2. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fecal Microbiota Transplantation (FMT) Market

  • 16.1. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fecal Microbiota Transplantation (FMT) Market

  • 17.1. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fecal Microbiota Transplantation (FMT) Market

  • 18.1. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fecal Microbiota Transplantation (FMT) Market

  • 19.1. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fecal Microbiota Transplantation (FMT) Market

  • 20.1. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fecal Microbiota Transplantation (FMT) Market

  • 21.1. Eastern Europe Fecal Microbiota Transplantation (FMT) Market Overview
  • 21.2. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fecal Microbiota Transplantation (FMT) Market

  • 22.1. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fecal Microbiota Transplantation (FMT) Market

  • 23.1. North America Fecal Microbiota Transplantation (FMT) Market Overview
  • 23.2. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fecal Microbiota Transplantation (FMT) Market

  • 24.1. USA Fecal Microbiota Transplantation (FMT) Market Overview
  • 24.2. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fecal Microbiota Transplantation (FMT) Market

  • 25.1. Canada Fecal Microbiota Transplantation (FMT) Market Overview
  • 25.2. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fecal Microbiota Transplantation (FMT) Market

  • 26.1. South America Fecal Microbiota Transplantation (FMT) Market Overview
  • 26.2. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fecal Microbiota Transplantation (FMT) Market

  • 27.1. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fecal Microbiota Transplantation (FMT) Market

  • 28.1. Middle East Fecal Microbiota Transplantation (FMT) Market Overview
  • 28.2. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fecal Microbiota Transplantation (FMT) Market

  • 29.1. Africa Fecal Microbiota Transplantation (FMT) Market Overview
  • 29.2. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fecal Microbiota Transplantation (FMT) Market Competitive Landscape And Company Profiles

  • 30.1. Fecal Microbiota Transplantation (FMT) Market Competitive Landscape
  • 30.2. Fecal Microbiota Transplantation (FMT) Market Company Profiles
    • 30.2.1. Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johns Hopkins Medicine Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Seres Therapeutics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Taconic Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Enterome Overview, Products and Services, Strategy and Financial Analysis

31. Fecal Microbiota Transplantation (FMT) Market Other Major And Innovative Companies

  • 31.1. Rebiotix Inc
  • 31.2. Finch Therapeutics Group Inc
  • 31.3. Locus Biosciences
  • 31.4. Yeda Research and Development Co. Ltd
  • 31.5. Microbiotica Limited
  • 31.6. CosmosID Inc
  • 31.7. AOBiome
  • 31.8. Synthetic Biologics Inc.
  • 31.9. Osel Inc.
  • 31.10. OpenBiome
  • 31.11. Asia Microbiota Bank
  • 31.12. Taymount Clinic
  • 31.13. MicroBiome Therapeutics LLC
  • 31.14. MaaT Pharma SA
  • 31.15. Kallyope

32. Global Fecal Microbiota Transplantation (FMT) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fecal Microbiota Transplantation (FMT) Market

34. Recent Developments In The Fecal Microbiota Transplantation (FMT) Market

35. Fecal Microbiota Transplantation (FMT) Market High Potential Countries, Segments and Strategies

  • 35.1 Fecal Microbiota Transplantation (FMT) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Fecal Microbiota Transplantation (FMT) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Fecal Microbiota Transplantation (FMT) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer